feed,title,long_url,short_url
Investors,Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunity,https://www.investors.com/news/technology/biotech-stock-centessa-pharmaceuticals-narcolepsy-treatment/,https://da.gd/FdPjcR
Investors,Viridian Spikes On A 'Bull-Case Scenario' For Eye Drug Considered Amgen Rival,https://www.investors.com/news/technology/viridian-therapeutics-amgen-rival-thyroid-eye-disease-tepezza/,https://da.gd/xt2bop
Investors,"Bank Stocks Rise, JPMorgan In Buy Zone With Fed's Barr To Speak",https://www.investors.com/news/bank-stocks-rise-jpmorgan-in-buy-zone-with-feds-barr-to-speak/,https://da.gd/ZNCggL
Investors,Apple Intelligence Won't Be Available For iPhone 16 Launch,https://www.investors.com/news/technology/apple-stock-iphone-16-launch-without-ai-features/,https://da.gd/E02wu
